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Abstract
Genetically modified mouse strains derived from embryonic stem (ES) cells have become essential tools for functional
genomics and biomedical research. Large scale mutagenesis projects are producing libraries of mutant C57BL/6 (B6) ES cells
to enable the functional annotation of every gene of the mouse genome. To realize the utility of these resources, efficient
and accessible methods of generating mutant mice from these ES cells are necessary. Here, we describe a combination of
ICR morula aggregation and a chemically-defined culture medium with widely available and accessible components for the
high efficiency generation of germline transmitting chimeras from C57BL/6N ES cells. Together these methods will ease the
access of the broader biomedical research community to the publicly available B6 ES cell resources.
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Introduction
The generation of genetically modified mouse strains by
homologous recombination in embryonic stem (ES) cells is a
major research tool in diverse fields of biology. Historically the
majority of manipulations have been performed in ES cells derived
from the 129 strain [1] comprised of a wide range of genetically
variable substrains not suitable for some studies, in particular
immunology [2] and neurobiology [3]. Germline transmission
breeding and subsequent backcrosses to C57BL/6 (B6) to generate
congenic strains delay functional studies and increase costs, while
at the same time genes closely linked to the original targeted locus
remain from the original ES cell genome and may confound
research results [4]. Together, these considerations led the large
scale mouse mutagenesis projects organized under the umbrella of
the International Knockout Mouse Consortium (IKMC) to select
B6-derived ES cells as the parental lines in which to mutate all
protein coding genes of mouse [5,6]. Improved methods for the
generation of germline transmitting chimeric mice from B6 ES cell
lines will make the IKMC and other B6 ES cell resources more
accessible to the broader biomedical research community.
B6 ES cell lines have been available since the early 1990s
[7,8,9]; however, in spite of the clear advantages of the inbred
background few targeted mutations have been published com-
pared to the widely used 129 ES cell lines [1]. B6 ES cells appear
to be less efficient in generating germline transmitting chimeras
[10,11,12,13]. A recent report with a large number of clones
showed only about 43% vs. 81% of germline transmitting clones
for B6 vs. 129S5 ES cells [14]. B6 ES cells have been shown to be
more difficult to maintain in culture [10,15] and more likely to
become aneuploid suggesting instability and deterioration in
standard culture conditions [1]. Furthermore microarray analysis
of gene expression patterns in cultured 129- and B6-derived ES
cells showed that B6 ES cells have a greater tendency to lose their
pluripotency in culture in standard 15% FBS LIF-supplemented
ES cell medium than 129 ES cells [16].
Various methods have been employed to address the apparent
specific requirements of B6 ES cells and to improve methods for
their derivation and culture. The use of RESGRO
TM medium
(Millipore) almost doubled the efficiency of B6 ES cell derivation
and generation of germline chimeras and completely ES cell-
derived animals by aggregation with tetraploid embryos [17]. The
use of optimized KnockOut
TM DMEM medium and chemically
defined KnockOut
TM Serum Replacement (KOSR; Invitrogen)
also facilitated the derivation of karyotypically stable and germline
competent B6 ES cells [18]. The addition of various signal
transduction pathway inducers and inhibitors have resulted in
further improvements in ES cell culture and chimera production
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non-permissive [19,20,21,22]. It is currently postulated that this
system of inhibitors constitutes a generic culture condition for the
maintenance of authentic pluripotency [23]. Here, we describe a
KOSR-based medium for the efficient generation of germline
chimeras using our B6-derived ES cell line, designated C2, and its
targeted subclones.
A variety of host embryos and methods have been used to
generate germline chimeras from B6 ES cells such as BALB/c and
C57BL/6-Tyr
c-2J/J (albino B6/J) blastocyst injection
[7,8,12,18,21,24,25] and outbred CD-1 [10] and Swiss Webster
(SW) [17] morula aggregation. Laser-assisted microinjection into
8-cell embryos has yielded completely ES cell-derived animals
[26]. Efficient germline transmission from IKMC targeted B6 ES
cell clones was demonstrated recently by Pettitt and colleagues
[27] using C57BL/6-Tyr
c-Brd blastocyst injections. However,
C57BL/6-Tyr
c-Brd animals are not easy to obtain; similar
C57BL/6-Tyr
c-2J mice available from The Jackson Laboratory
have a relatively high cost and often require the maintenance of an
in-house breeding colony; finally, the classical BALB/c host strain
is not very efficient for producing a good number of quality
embryos. For these reasons, alternative host embryos for B6 ES
cells have been investigated, e.g. C3H6BALB/c [28].
Aggregation of cleavage stage embryos with ES cells [29] offers
an accessible method for generating ES cell chimeric mice. Since
the early 1990s we have exclusively used the aggregation method
to generate multiple genetically modified mouse strains from
129S16129X1 (R1) [30] and 129S6B6F1 (G4) [31] ES cells. Here,
we show that ICR morula aggregation is also an efficient method
for producing germline transmitting chimeras from B6N ES cell
lines. Taken together, the improved culture medium and a more
accessible technique for generating chimeras will improve
accessibility of the IKMC and other B6 ES cell resources to the
broader biomedical research community.
Results
Conditioned ES cell medium significantly improves
chimera production from B6-derived C2 ES cells
Blastocyst injection is the most common method for producing
mouse ES cell chimeras. 8-cell or morula microinjections can be
performed with the conventional technique routinely used for
blastocysts [32,33] as well as by introducing a slit cut or hole in the
zona pellucida using a glass needle [34,35], piezo drill [36,37] or
laser [26]. Both blastocyst and 8-cell stage embryos have been used
to generate chimeric mice with B6 ES cells [12,21,26].
Microinjections require specialized equipment and skilled person-
nel. To test whether the more accessible method of morula
aggregation could efficiently generate B6-derived mouse ES cell
chimeras, we attempted morula aggregation using the B6N-
derived cell line C2.
C2 ES cells were derived using standard ES cell medium (FBS-
DMEM) and methods [38] and were aggregated with ICR
embryos to generate chimeras. Although a number of male
chimeras with significant coat colour contribution were generated,
a poor rate of germ line transmission was observed even at early
passage (data not shown) corresponding to the original findings of
Auerbach et. al. [10] with their B6-derived ES cells. RESGRO
TM
is an FBS-based medium conditioned by rabbit fibroblast cells
transduced with genomic rabbit LIF and shown to be efficient for
derivation and generation of germline chimeras using several
mouse strains including B6 [17]. Culture of parental C2 ES cells
and its transgenic subclones in RESGRO
TM resulted in higher
numbers of chimeras, increased degree of chimerism and efficient
germline transmission (data not shown). Taken together, these
observations led us to hypothesize that culture conditions have a
major impact on the efficiency of chimera generation with B6 ES
cells. To quantitatively assess the effect of culture medium on the
production of chimeras from B6-derived ES cells, we undertook a
comparison of different culture media. The four culture media
tested were standard FBS-DMEM, where the FBS had been lot
selected based on the ability to support completely ES cell-derived
embryo and pup formation with F1 hybrid-derived (G4) ES cells in
the tetraploid complementation assay; RESGRO
TM medium
(Millipore); VGB6 conditioned medium, a proprietary formulation
generously provided by Regeneron Pharmaceuticals, Inc. (Tarry-
town, NY); and a defined medium comprised of KnockOut
TM
DMEM (Invitrogen) with KnockOut
TM Serum Replacement
(Invitrogen) and supplemented with two inhibitors (2i) [20,21]
(KOSR+2i; see Materials and Methods). The culture media were
tested by passaging parental C2 ES cells in the media and then
testing their ability to generate chimeric animals based on coat
colour contribution.
C2 ES cells were passaged in RESGRO
TM medium for several
passages (Table 1). After at least three passages, ES cells were
aggregated with ICR morula to produce chimeric animals.
Consistent with previous reports [1] and our own unpublished
data, increasing passage number resulted in a decrease in the
chimeric potential of C2 cells with the proportion of .50%
chimeric males (as judged by coat colour) decreasing from 32% to
10% among live born animals in four passages (p=0.1274, Fisher’s
exact test) and the number of .50% chimeric males decreased
from 6 to 2 (Table 1).
The expense of RESGRO
TM medium limits its use for
applications like gene targeting that require large amounts of
medium during selection, subcloning, and expansion. To mimic
the various culture conditions used in ES cell targeting, we
passaged cells sequentially in combinations of RESGRO
TM,
VGB6 medium, or FBS-DMEM. As few as three passages in
FBS-DMEM can completely abrogate ES cell contribution to
chimeric mice enabled by the previous growth in RESGRO
TM
medium (Table 1). This can however be rescued by as few as three
passages in VGB6 medium (Table 1). Of note, is that no
statistically significant difference in the proportion of chimeras
born among pups was observed after culture in RESGRO
TM or
FBS-DMEM before aggregation (p=0.551, Fisher’s exact test),
while a difference was observed between these two media and
culture in VGB6 medium with passage 12 C2 cells (Table 1;
p=0.0135 and p=0.0003, respectively, Fisher’s exact test). These
data enabled us to develop a cost-effective gene targeting approach
with the media-intensive selection, subcloning and expansion for
screening and cryopreservation done in FBS-DMEM followed by
passage of targeted clones in conditioned medium before
aggregation.
Targeted ES cell clones will contribute to the germline of
chimeric mice after passage in conditioned medium
C2 ES cells, from a pool expanded in VGB6 conditioned
medium generously provided by Regeneron Pharmaceuticals, Inc.,
were cultured and manipulated in FBS-DMEM during manipu-
lations for gene targeting. After PCR screening to identify targeted
subclones, positive clones were each thawed into FBS-DMEM,
expanded in 1–2 passages and frozen in vials. After genotype
confirmation of expanded clones, cells were thawed in RE-
SGRO
TM, VGB6 or KOSR medium, passaged three to four times
and used for aggregation with ICR embryos. While some clone-to-
clone variation was seen with respect to the number and degree of
chimerism among progeny (Table S1), on average targeted clones
B6 ESC Chimeras by Aggregation
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TM resulted in lower numbers and proportion of
chimeric mice among live-born pups and a lower number of chimeric
males with .50% coat-colour contribution than VGB6-cultured ES
cell chimeras (Table 2). Survival of chimeras from birth to weaning did
not differ significantly between these two media (p=0.1119, Fisher’s
exact test). Most important, RESGRO
TM-a n dV G B 6 - c u l t u r e dE S
cells showed identical patterns of germline transmission for these five
targeted clones with similar frequencies of germline transmission
among tested chimeras (5/18 and 9/17, respectively; p=1.0000,
Fisher’s exact test). In these experiments we also evaluated KOSR
medium for the ability to generate high-contribution and germline
transmitting chimeras as it was previously shown to improve the
derivation and pluripotency of B6 ES cells [18]. Of the five clones
tested, only one transmitted through the germline of chimeric mice
after culture in KOSR medium (Table S1). The advantage of
chemically-defined media is exemplified by the lot-to-lot variation that
can be seen among FBS and conditioned-media lots (unpublished data)
which can be compounded by the scarcity of supply and expense in
testing and use of these media. Given that KOSR medium enabled
germline transmission of one targeted C2 clone and serves as the basal
medium for conditioned VGB6 medium [26], we decided to test this as
a basal medium supplemented with 2i inhibitors [20] to develop a
chemically defined ES cell medium for production of high-level
chimeras and good germline transmission rates.
KOSR+2i enables highly efficient generation of germline
transmitting chimeras from targeted B6N-derived C2 ES
cells
Several groups have reported that the use of inhibitors of the
WNT, FGF and ERK signal transduction pathways significantly
improved both the derivation of new ES cell lines, including those
from C57BL/6, and their subsequent potential to contribute to
chimeric mice and germline transmission [20,39,40]. This so-
called 3i medium (supplemented with the FGF receptor inhibitor
SU5402, the MEK inhibitor PD184352, and the GSK3 inhibitor
CHIR99021) is now commercially available (iSTEM Mouse ES
cell Media, Stem Cell Sciences, Ltd.). Work with rat ES cells
demonstrated that the use of two inhibitors (2i; MEK inhibitor
PD0325901 and GSK3 inhibitor CHIR99021) resulted in rat ES cells
Table 1. Generation of chimeras by ICR morula aggregation from C57BL/6NTac-C2 ES cells cultured in different media.
No. .50% male
Medium 1 Medium 2 Medium 3 No. embryos No. pups born chimeras (% of
Passage
{ (No. passages) (No. passages) (No. passages) transferred (% of embryos) live born)
11 RESGRO
TM (7) - - 100 19 (19%) 6 (32%)
a
12 RESGRO
TM (8) - - 200 45 (23%) 7 (16%)
14 RESGRO
TM (7) RESGRO
TM (3) - 176 20 (11%) 2 (10%)
a,c
14 RESGRO
TM (7) FBS (3) - 51 20 (39%) 0 (0%)
b,c
14 RESGRO
TM (7) VGB6 (3) - 36 6 (17%) 3 (50%)
b
12 VGB6 (3) FBS (4) - 96 32 (33%) 1 (3%)
d,e
12 VGB6 (3) RESGRO
TM (4) - 80 20 (25%) 2 (10%)
d,f
12 VGB6 (3) VGB6 (4) - 80 13 (16%) 7 (54%)
e,f
15 VGB6 (3) FBS (3) FBS (3) 165 37 (22%) 0 (0%)
h
15 VGB6 (3) FBS (3) VGB6 (3) 119 25 (21%) 17 (68%)
g,h
15 VGB6 (3) VGB6 (3) VGB6 (3) 67 11 (16%) 5 (45%)
g,h
{C2 cells derived and cultured in FBS-DMEM until passage 4 when used for pool expansion in RESGRO or passage 5 when used for pool expansion in VGB6.
Fisher’s exact test was used for pair-wise comparisons
ap=0.1274;
bp=0.0077;
cp=0.4872;
dp=0.5511;
ep=0.0003;
fp=0.0135;
gp=0.2725. Chi square test was used for
362 comparison
hp,0.0001.
doi:10.1371/journal.pone.0011260.t001
Table 2. Generation of chimeras by ICR morula aggregation and germline transmission from 5 targeted C2 subclones cultured in
parallel in RESGRO
TM or VGB6 medium.
RESGRO
TM VGB6
Average no. embryos transferred 70 62
Average no. pups born (% of embryos) 16.4 (23%)
a 8.2 (13%)
a
Average no. chimeras born (% of live born) 4.4 (27%)
b 5.6 (68%)
b
Average no. male chimeras weaned (% of chimeras born) 2.8 (64%)
c 3.4 (61%)
c
Average no. .50% chimeric males (% of live born) 2.6 (16%)
d 2.8 (34%)
d
GLT rate for clones
e 60% 60%
GLT rate for genes
e 60% 60%
Fisher’s exact test was used for pair-wise comparisons as indicated by superscripts:
ap=0.0009;
bp,0.0001;
cp=0.1119;
dp=0.0359.
ePercent germline transmission rate calculated as a proportion of those clones that produced at least one .50% male chimera for testing.
doi:10.1371/journal.pone.0011260.t002
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to sex-convert host embryos than those derived and cultured with 3i
medium [41,42]. The use of 2i-supplemented medium has also allowed
the successful derivation of germline competent NOD mouse ES cells
[22]. Our limited success with KOSR reported above and the use of
KOSR for both deriving B6 ES cell lines and generating chimeras [18]
led us to hypothesize that the addition of 2i to KOSR would improve
the ability of ES cells to contribute to chimeric mice and germline
transmission potential. To evaluate this, we supplemented KOSR
medium with 1 mM of the mitogen-activated protein kinase inhibitor
PD0325901 and 3 mM of the glycogen synthase kinase-3 inhibitor
CHIR99021 (KOSR+2i) and undertook experiments similar to those
described above using 26 targeted subclones of C2 ES cells. We then
compared the effects of ES cell culture in KOSR+2i and VGB6 media
on the generation of germline transmitting chimeric mice.
As with RESGRO
TM and VGB6 media, we observed clone-to-
clone variation between KOSR+2i- and VGB6-culturedEScells(e.g.
N00005, N00086, N00343; Table S2). Table 3 shows that on
average, aggregation with cells cultured in KOSR+2i resulted in a
similar number of pups being born (17.5 versus 15.0, p=0.0052,
Fisher’s exact test), but the number and proportion of chimeras born
(scored as black-eyed pups at birth) was higher with cells cultured in
VGB6 medium (8.4 and 52% cf. 9.7 and 70%, p,0.0001, Fisher’s
exact test). However, the better survival of chimeras born after ICR
morula aggregation with KOSR+2i-cultured ES cells compared to
V G B 6 - c u l t u r e dc e l l s( 8 . 0a n d9 6 %cf. 7.2 and 74%, p,0.0001,
Fisher’s exact test) resulted in approximately the same average
number of male chimeras being weaned (Table 3, 6.263.9 and
6.364.6, respectively). On average, more of those chimeras were
scored at .50% ES cell contribution by coat colour among live born
pups from VGB6-cultured than KOSR+2i-cultured ES cells (5.8 or
37% and 4.3 or 24% of pups born, respectively; p,0.0001, Fisher’s
exact test). The male:female ratio of KOSR+2i-cultured ES cell
chimeras was 3.4:1 compared to 7.5:1 for VGB6-cultured ES cell
chimeras, suggesting that the VGB6-cultured cells had a higher
contribution potential. In spite of this, overall germline transmission
rates were similar between the two media (Table 3).
Germline transmission is not guaranteed with 100% ES
cell derived chimeras
As shown above, we were able to generate 100% ES cell derived
chimeras (as judged by coat colour) using these culture conditions
and aggregation method with more 100% by coat colour animals
obtained with VGB6-cultured ES cells than with KOSR+2i-
cultured ES cells (respectively 2.9 and 1.9 on average per clone, or
19.6% and 11.4% of live born pups, among those clones giving
100% ES cell derived chimeras, p=0.0064, Fisher’s exact test;
Table S3). For each clone that generated high-level contribution
chimeras (.50% by coat colour), we routinely tested up to 6
chimeras for germline transmission of the ES cell genome. As
shown in Figure 1, for analysis of germline transmission rates we
grouped chimeras according to ES cell contribution as judged by
coat colour. Chimeras generated with ES cells cultured in either
medium showed a positive correlation between degree of
chimerism and germline transmission rates. For both KOSR+2i-
and VGB6-cultured ES cells, the decrease in the proportion of
tested chimeras showing germline transmission was statistically
significant (Figure 1A, p=0.0359 and p,0.0001, respectively, Chi
square for trend). Among tested chimeras 25–45% were sterile
whether ES cells used for aggregation were cultured in VGB6 or
KOSR+2i medium (Figure 1A and Table S3; p.0.6, Fisher’s
exact test) and was not correlated with the degree of chimerism
(p=0.4328, Chi square for trend). Sterility among ES cell
chimeras has been reported and may in some cases be due to
the failure of the ES cell to completely sex-convert the chimeric
animal, resulting in sterile or hermaphroditic animals [38].
Surprisingly, however, several of the 100% by coat colour ES
cell chimeras were fertile but did not transmit the ES cell genome.
No difference in either the number or proportion of germline
transmitting chimeras was observed for the two media (34% or
58/88 KOSR+2i and
59/90 VGB6, p=1.0000, Fisher’s exact test).
For VGB6-cultured ES cell chimeras germline transmission
occurred for 73% (
19/26) of clones tested and 78% (
18/23)o f
targeted genes; similarly for KOSR+2i-cultured ES cell chimers,
germline transmission occurred for 77% (
20/26) of clones tested
and 87% (
20/23) of genes (Table 3, Table S2 and Table S3;
p=0.7647 and p=0.4801, Fisher’s exact test, for clones and genes,
respectively).
KOSR+2i is an appropriate medium for culture of B6-
derived ES cell lines
The success of KOSR+2i medium in the culture of several
different subclones of targeted C2 ES cells provided strong
evidence that this medium would be of wide utility for the culture
of B6-derived ES cells and subsequent generation of chimeric
mice. At the Toronto Centre for Phenogenomics Transgenic Core,
Table 3. Generation of chimeras by ICR morula aggregation and germline transmission from 26 targeted C2 subclones cultured in
parallel in KOSR+2i or VGB6 medium.
KOSR+2i VGB6
Average no. embryos transferred 80 81
Average no. pups born (% of embryos) 17.5 (22%)
a 15.0 (19%)
a
Average no. chimeras born (% of live born) 8.4 (48%)
b 9.7 (65%)
b
Average no. male chimeras weaned (% of chimeras born) 6.2 (74%)
c 6.3 (65%)
c
Average no. .50% chimeric males (% of live born) 4.3 (24%)
d 5.8 (37%)
d
No. clones tested 26 26
No. genes tested 23 23
GLT rate for clones
g 77%
e 73%
e
GLT rate for genes
g 87%
f 78%
f
Pair-wise comparisons for statistical analysis are indicated by superscripts: Chi sqare
ap=0.0052; Fisher’s exact test
b,dp,0.0001;
cp=0.0467;
ep=0.7647;
fp=0.4801.
gPercent germline transmission rate calculated as a proportion of all clones tested, including those that did not produce chimeras.
doi:10.1371/journal.pone.0011260.t003
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chimeric mice using B6-derived ES cells available from the
International Knockout Mouse Consortium (IKMC) repositories
(see http://www.knockoutmouse.org for more information). These
experiments are performed on request as a service to the research
community. In addition to the NorCOMM clones used in the
experiments above, we have aggregated another 8 targeted clones
and 1 gene trap clone (7 genes) from IKMC resources. These
clones were cultured in VGB6 and/or KOSR+2i media for at least
three passages followed by the production of aggregation
chimeras. Germline transmission of 8 of 9 clones was obtained;
with 4 of 6 clones cultured in KOSR+2i producing germline-
transmitting chimeras (Table 4).
Discussion
The genetic background of mouse strains can affect the
phenotype of mutant lines and must therefore be carefully
considered when interpreting data from mouse models of disease
and development. Using ES cell lines of the same genetic
background as the mouse model to be developed simplifies
analyses and reduces the time and cost involved in producing
appropriate mouse models. Historically, B6 ES cell lines have not
been widely used due to reports of genomic instability and a
tendency to differentiate in culture [10,11,12,13]. Here we applied
the extensive work improving the derivation of new ES cell lines
from strains previously identified as non-permissive [20,21,22] to
develop a defined culture medium, with widely available and
accessible components, that enables high efficiency generation of
B6 ES cell chimeric mice and subsequent germline transmission.
We demonstrate that culture media can significantly affect the
ability to generate high-contribution chimeras and that this
KOSR+2i medium can be used to improve or rescue cell lines
that have been exposed to suboptimal culture conditions (Table 3),
restoring their ability to generate high-level chimeras as judged by
coat colour. These results are similar to those using 3i medium
reported during the preparation of this manuscript [40] and
described for C57BL6/J-derived ES cell lines using a GSK3
inhibitor [43]. To date we have generated germline transmitting
chimeras for targeted and trapped B6 ES cell clones from six
Figure 1. Representation of fertility and germline transmission status of chimeric mice derived from C57BL/6NTac-C2 targeted
clones based on degree of coat colour chimerism. A. Percentage of mice derived from the same ES cell lines in the same experiments cultured
in KOSR+2i or VGB6 prior to aggregation and tested for germline transmission of the ES cell genome. B. Number of mice in each category from A.
doi:10.1371/journal.pone.0011260.g001
Table 4. Generation of germline transmitting chimeras by ICR morula aggregation with targeted B6N ES cell subclones cultured in
different types of media.
No. GLT/No. clones aggregated
a
Source of targeted ES cell clones Parental ES cell line KOSR+2i VGB6
KOMP JM8.N4 2/3 2/3
KOMP JM8 nd 1/1
KOMP VGB6 1/2 1/3
EuCOMM JM8.F6 nd 1/1
TIGM B6 1/1 nd
NorCOMM C2 20/26 22/31
nd, not done.
aNumber of clones aggregated includes those for which no .50% chimeric males were recovered.
doi:10.1371/journal.pone.0011260.t004
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KOSR+2i medium can be of widespread use for the derivation of
germline transmitting B6 ES cell chimeras.
Clone to clone variation exists both in the ability to derive high-
contribution chimeras and the number and quality of chimeras
derived from the same cell line in the different media tested (Table
S1 and Table S2). In our limited experience, we have found that
repeating the experiment with the same clone to generate more
chimeric mice will often enable recovery of germline transmitting
chimeric mice. However, our preference is to repeat the
experiment with an independent clone for the same targeted or
trapped gene, if another is available.
Blastocyst microinjection of albino B6 or BALB/c embryos has
been broadly applied for the production of chimeric mice with B6
ES cells. Morula and 8-cell microinjection have also been used
over the years to generate chimeras [32,33,34,35]. In fact it was
demonstrated that although fewer pups develop to term after
morula injection, a higher percentage of them represent high
contribution chimeras with higher frequencies of germline
transmission compared to injections into blastocyst host embryos
[32,34,35,44]. These results demonstrated the role of the
developmental stage of host embryos that arguably may be even
more important than optimal combinations of ES cell and host
embryo strains [25,45]. Recent developments in morula microin-
jection techniques include the use of a piezo drill [36,37] and laser
[26] with the last report demonstrating the derivation of
completely ES cell derived mice using 8-cell subzonal injection.
Convential microinjection of morula also produced completely ES
cell derived mice, as judged by coat colour [40]. It is important to
note that in these reports of completely ES cell derived mice,
particular attention is paid to ES cell culture media [26,40,43]. All
microinjection protocols require expensive specialized equipment
and highly trained operators. Aggregations do not require
sophisticated microinjection equipment, only a stereomicroscope
and standard embryo manipulation techniques. Inexpensive
outbred albino stocks are readily available and provide sufficient
numbers and quality of embryos for most purposes. Optimal
embryo culture conditions during aggregations are of utmost
importance as zona-free embryos are more sensitive and
aggregates are cultured longer than injected blastocysts. Aggrega-
tion and morula/8-cell microinjection methods are not dependent
on the specific developmental stage of the blastocyst suitable for
injections. Our, and recently published [43], data show that the
aggregation method produces results comparable to those
obtained with laser-assisted [26] or conventional subzonal
microinjection of 8-cell stage embryos [40] as long as ES cells
are maintained in optimal culture conditions. Hence we conclude
that aggregation is an efficient and accessible method for the
generation of chimeras for establishing new mutant mouse lines
from B6 ES cells.
Based on the recent report of microinjection of 3i-cultured B6
ES cells into 8-cell stage ICR embryos to generate germline
transmitting chimeras [40], it is possible that conventional or any
other method of injection into 8-cell or other E2.5 stage outbred
albino embryos will produce similar results as long as attention is
paid to the culture conditions of B6 ES cells. B6 ES cells seem to
do better in the chemically defined KOSR basal medium rather
than FBS-DMEM that exhibits lot-to-lot variation that cannot be
controlled when cells are transferred between production centres,
repositories and receiving laboratories. Supplementation of KOSR
medium with 2i provides an accessible and available alternative to
scarce and/or costly proprietary media.
In conclusion, the methods and reagents reported here will
make the IKMC and other B6 ES cell resources more accessible to
the broader biomedical research community, reducing the costs
and time associated with the development of new models for the
study of disease and development.
Materials and Methods
Ethics Statement
All animal work was carried out following Canadian Council on
Animal Care guidelines for Use of Animals in Research and
Laboratory Animal Care under protocols approved by the
Toronto Centre for Phenogenomics Animal Care Committee;
animal use protocol numbers 11-01-0008a-H and 10-11-0153-H.
Mice
C57BL/6NTac mice were obtained from Taconic for deriva-
tion of ES cells. ICR (Harlan) outbred albino stock was used as
embryo donors for aggregation with ES cells, CD-1 (Charles
River) females were used as pseudopregnant recipients. Animals
were maintained on 12 h light/dark cycle and provided with food
and water ad libitum in individually ventilated units (Techniplast) in
the specific-pathogen free facility at the Toronto Centre for
Phenogenomics.
Derivation of ES cells
B6 ES cells were established following the standard methods
[38]. Briefly, three week old C57BL/6NTac females were
superovulated and mated, and E2.5 embryos were collected from
the oviducts and cultured for two days in microdrops of KSOM
with amino acids (Millipore) under mineral oil at 37uC in 94% air
6% CO2. After 48 h culture, expanded blastocysts were plated
individually in 4-well plates (Nunc) containing mitomycin-C
(Sigma) treated mouse embryonic fibroblasts (MEF) and FBS-
DMEM ES cell medium consisting of high glucose DMEM
supplemented with 15% FBS (Hyclone, tested to support
generation of chimeras from 129 ES cells), 2 mM glutamine,
1 mM Na Pyruvate, 0.1 mM non-essential amino acids, 50 U/ml
penicillin and streptomycin (all from Invitrogen), 0.1 mM 2-
mercaptoethanol (Sigma) and 1000 U/ml LIF (prepared with LIF
producing plasmid) [46]. Five days after plating, ICM outgrowths
were transferred into 30 ml of 0.05% Trypsin-EDTA (Invitrogen),
dissociated using a mouth pipette with pulled glass capillary and
plated on MEF. Undifferentiated ES cell colonies were then
gradually expanded to establish ES cell lines. Lines were selected
based on undifferentiated morphology, the presence of Y
chromosome by PCR and normal karyotype by chromosome
counting [38].
ES cell culture
ES cells were grown at 37uC in 95% air 5% CO2 on MEF
obtained from TgN(DR4)1Jae/J mice (http://jaxmice.jax.org/
strain/003208.html) at all times except one passage on gelatinized
tissue culture plates before aggregation based on standard
protocols [38]. Cells were fed daily and passaged when they
reached 70–80% confluency. 0.05% Trypsin-EDTA (Invitrogen)
was used for the passage of cells grown in FBS-DMEM and
Accutase (Millipore SF006) for ES cells grown in KnockOut
TM
Serum Replacement (SR). Four types of media were used: 1). FBS-
DMEM ES cell medium as described above but supplemented
with 2 mM GlutaMAX
TM (Invitrogen) instead of L-glutamine,
500 U/ml LIF (Millipore ESG1107), 15% FBS (Invitrogen, lot
#421412). 2). RESGRO
TM (Millipore) medium used for subclon-
ing according to the manufacturer instructions. 3). VGB6 medium
containing 15% SR was conditioned by L-cells (ATCC # CRL-
2647) and generously provided by Regeneron Pharmaceuticals,
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KnockOut
TM DMEM supplemented with 15% KnockOut
TM
Serum Replacement, 1 mM Na Pyruvate, 0.1 mM non-essential
amino acids, 0.1 mM 2-mercaptoethanol, 4 mM GlutaMAX
TM,
50 U/ml penicillin/streptomycin (all from Invitrogen), 200 U/ml
LIF (Millipore ESG1107), 5 mg/ml Insulin (Sigma I0516), 1 mMo f
the mitogen-activated protein kinase inhibitor PD0325901 (Stem-
Gent 04-0006) and 3 mM of the glycogen synthase kinase-3
inhibitor CHIR99021 (StemGent 04-0004).
Targeting C2 ES cells
Targeting constructs and targeted ES cell lines were generated
by the NorCOMM Project and are available at the Canadian
Mouse Mutant Repository (www.cmmr.ca). Briefly, approximately
2610
6 C2 ES cells were thawed onto a 6-mm tissue culture-treated
dish containing irradiated MEFs, expanded over three passages,
trypsinized using 0.05% Trypsin (Invitrogen) and centrifuged to
remove media. Cells were washed once with electroporation buffer
(Millipore), centrifuged and resuspended in electroporation buffer.
8610
6 C2 ES cells were transfected with 5 mg of linear DNA in a
total volume of 750 mL in a 4-mm electrode gap cuvette using
Biorad Gene Pulser (250 V, 500uF Capacity and ? OhMs),
chilled on ice for 5 minutes and then plated onto a 100-cm tissue
culture-treated dish with 1610
6 MEF/plate in FBS-DMEM.
Selection with 50–100 mg/ml of G418 was started 24 h post-
transfection. After 9–10 days of selection with G418, depending on
the construct, colonies were picked and replicated for cryopres-
ervation and DNA analysis.
High throughput genotyping was performed by 96-well PCR
using Phire polymerase (NEB) with a gene specific primer 59 to the
end of the 59 homology arm and an internal vector primer. Once
correct homologous recombination of the short arm was
confirmed three clones for each vector were expanded in FBS-
DMEM. Cells were cryopreserved and DNA was isolated for
confirmation of expanded clones prior to aggregation. Long range
PCR was performed using Expand Long enzyme (Roche) with a
gene specific primer 39 of the end of the 39 homology arm and two
short internal PCRs were done using Phire polymerase (NEB) to
confirm the internal sequences critical to the function of the
targeted trap cassette. After sequence confirmation of all four PCR
products, one clone was selected for aggregation. Cells were
thawed into one of the media formulations described above and
passaged three to four times prior to aggregation.
Generation of chimeras
Details of morula aggregation can be found in [38]. Briefly,
embryos were collected at day E2.5 from superovulated ICR
(Harlan) female mice. Zonae pellucidae of embryos were removed
by treatment with acid Tyrode’s solution (Sigma). ES cell colonies
were briefly treated with 0.05% Trysin-EDTA or Accutase to form
loosely connected clumps of 7–10 cells. Each zona-free embryo
was aggregated with a clump of 7–10 cells inside depression wells
made in the plastic dish with an aggregation needle (BLS Ltd,
Hungary) and cultured overnight in microdrops of KSOM with
amino acids (Millipore MR-121D) under mineral oil at 37uCi n
94% air/6% CO2. The next morning morulae and blastocysts
were transferred into the uteri of 2.5-days post-coitum (dpc)
pseudopregnant CD-1 (Charles River) females previously mated
with vasectomized males. Chimeras were identified at birth by the
presence of black eyes and later by coat pigmentation. Chimeric
males with more than 50% coat colour contribution were
individually bred with ICR females. Tissues from ES cell derived
pups identified by eye pigmentation at birth were collected for
genotype confirmation and chimera-transmitters were immediate-
ly mated with C57BL/6N females to establish mutant strains on
B6 background.
Statistical Analysis
The statistical significance of differences in the proportion of
pups or chimeras born after ICR morula aggregation of ES cells
cultured under different conditions was calculated using Fisher’s
exact test for 262 tables (pair-wise comparisons) or Chi square test
for 263 tables (series comparisons) in Prism 5 (GraphPad
Software, Inc.). A p value#0.05 was deemed to indicate a
statistically significant difference.
Supporting Information
Table S1 Number, chimerism and GLT data for mice derived
from targeted C57BL/6NTac-C2 clones cultured in either
RESGROTM, VGB6, or KOSR immediately before aggregation.
Raw data for Table 2.
Found at: doi:10.1371/journal.pone.0011260.s001 (0.01 MB
PDF)
Table S2 Number, chimerism and GLT data for mice derived
from targeted C57BL/6NTac-C2 clones cultured in either
KOSR+2i or VGB6 immediately before aggregation. Raw data
for Table 3.
Found at: doi:10.1371/journal.pone.0011260.s002 (0.02 MB
PDF)
Table S3 Germline transmission test results for individual
chimeric mice derived from targeted C57BL/6NTac-C2 clones.
Raw data for Figure 1.
Found at: doi:10.1371/journal.pone.0011260.s003 (0.01 MB
PDF)
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